Unresolved issues in Pancreatic Cancer (Ongoing)

Posted On 2021-02-07 16:02:30



This series on "Unresolved issues in Pancreatic Cancer" is edited by Professor Savio George Barreto from Hepatobiliary & Oesophagogastric Unit, Division of Surgery & Perioperative Medicine, Flinders Medical Centre, Bedford Park, Adelaide, South Australia, Australia; College of Medicine & Public Health, Flinders University, South Australia, Australia.

Savio George Alberto da Piedade Barreto, MS, FRACS, PhD
Hepatobiliary & Oesophagogastric Unit, Division of Surgery & Perioperative Medicine, Flinders Medical Centre, Bedford Park, Adelaide, South Australia, Australia; College of Medicine & Public Health, Flinders University, South Australia, Australia

Dr. Barreto is a Gastrointestinal and Hepato-Pancreato-Biliary (GI & HPB) surgeon and researcher. Dr Barreto obtained his fellowship in GI & HPB Surgical Oncology at the Tata Memorial Hospital in Mumbai. He subsequently trained in Liver Transplant Surgery in South Australia. His career includes appointments as Consultant Surgical Oncologist at the Department of GI & HPB Surgical Oncology, Tata Memorial Centre, Mumbai India and Consultant Surgeon in the Department of GI Surgery, GI Oncology and Bariatric Surgery, Medanta – The Medicity. He is a Fellow of the Royal Australasian College of Surgeons and a Senior Lecturer in the College of Medicine and Public Health, Flinders University, South Australia. He is currently the South Australia Portfolio Advisor for the MD Advanced Studies Programme, College of Medicine and Public Health, Flinders University, South Australia.

Dr Barreto secured his Doctor of Philosophy degree from Flinders University, South Australia for his research into the pathophysiology and treatment of acute pancreatitis. Dr Barreto’s interests focus on the basic science and surgical aspects of acute pancreatitis, pancreatic, and gallbladder cancer. He has published a Carcinogenesis model in Gallbladder cancer to aid the understanding of the development of the cancer and to further therapy-directed research. He, along with Professor John Windsor, have proposed the first evidence-based definition of early gastric cancer. Dr. Barreto has authored more than 200 clinical and basic science research papers as well as book chapters on GI and HPB-related topics and has been invited to lecture on his work all over the world. He is the Associate Editor for the Indian Journal of Surgery. He is a member of the ISGPS and serves on the Editorial Boards for Pancreatology and World Journal of Surgery, amongst others. He is the Editor of the Book ‘Surgical Diseases of the Pancreas and Biliary Tree’. He is a member of the Indian Council of Medical Research Task force group that developed the guidelines for managing Pancreatic, Gastric, and Neuroendocrine cancers in India.

Series outline:

  1. Screening in Pancreatic Cancer
  2. Diabetes Mellitus and Pancreatic Cancer - which one is the chicken, and which the egg?
  3. How close are we to completely defining the genetic landscape of Pancreatic Cancer?
  4. Neoadjuvant therapy in resectable pancreatic cancer - is the way forward!
  5. Upfront surgery and adjuvant therapy for resectable Pancreatic Cancer - is still the only way
  6. Is enhancing recovery after Pancreatic cancer surgery even possible?
  7. Do Arterial resections improve survival in Pancreatic cancer?
  8. Minimally invasive surgery for Pancreatic cancer - are we there yet?
  9. Immunotherapy in Pancreatic Cancer - an emerging role

Disclosure:
The series “Unresolved issues in Pancreatic Cancer” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Dr. Savio George Barreto served as the unpaid Guest Editor for the series.